Preprint Review Version 1 This version is not peer-reviewed

Genetically Determined Syndromes Associated with an Increased Risk of Glioma – the Use of Photodynamic Therapy (PDT)

Version 1 : Received: 1 July 2024 / Approved: 2 July 2024 / Online: 2 July 2024 (13:16:55 CEST)

How to cite: Inglot, J.; Strzelczyk, J. K.; Bartusik-Aebisher, D.; Aebisher, D. Genetically Determined Syndromes Associated with an Increased Risk of Glioma – the Use of Photodynamic Therapy (PDT). Preprints 2024, 2024070252. https://doi.org/10.20944/preprints202407.0252.v1 Inglot, J.; Strzelczyk, J. K.; Bartusik-Aebisher, D.; Aebisher, D. Genetically Determined Syndromes Associated with an Increased Risk of Glioma – the Use of Photodynamic Therapy (PDT). Preprints 2024, 2024070252. https://doi.org/10.20944/preprints202407.0252.v1

Abstract

In this review, we have included current information on the use of photodynamic therapy in the treatment of gliomas. We mainly focused on the discussion and regarding the use of photodynamic therapy in patients with genetically determined syndromes that are associated with an increased risk of glioma. The review also uses information on genetic syndromes that are associated with an increased risk of glioma.

Keywords

: brain tumors; photodynamic therapy, genetically determined syndromes.

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.